153 related articles for article (PubMed ID: 7686395)
1. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
Lupu F; Bergonzelli GE; Heim DA; Cousin E; Genton CY; Bachmann F; Kruithof EK
Arterioscler Thromb; 1993 Jul; 13(7):1090-100. PubMed ID: 7686395
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
[TBL] [Abstract][Full Text] [Related]
3. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.
Shireman PK; McCarthy WJ; Pearce WH; Patterson BK; Shively VP; Cipollone M; Tamarina N; Verrusio EN; Kwaan HC
J Vasc Surg; 1996 May; 23(5):810-7; discussion 817-8. PubMed ID: 8667502
[TBL] [Abstract][Full Text] [Related]
5. Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells.
Schneider DJ; Absher PM; Ricci MA
Circulation; 1997 Nov; 96(9):2868-76. PubMed ID: 9386151
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator expression in human atherosclerotic lesions.
Lupu F; Heim DA; Bachmann F; Hurni M; Kakkar VV; Kruithof EK
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1444-55. PubMed ID: 7670960
[TBL] [Abstract][Full Text] [Related]
7. Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins.
Arnman V; Nilsson A; Stemme S; Risberg B; Rymo L
Thromb Res; 1994 Dec; 76(5):487-99. PubMed ID: 7900096
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls.
Chomiki N; Henry M; Alessi MC; Anfosso F; Juhan-Vague I
Thromb Haemost; 1994 Jul; 72(1):44-53. PubMed ID: 7974374
[TBL] [Abstract][Full Text] [Related]
9. Immunoelectron microscopic localization of plasminogen activator inhibitor type 1 (PAI-1) in smooth muscle cells from morphologically normal and atherosclerotic human arteries.
Taatjes DJ; Wadsworth M; Absher PM; Sobel BE; Schneider DJ
Ultrastruct Pathol; 1997; 21(6):527-36. PubMed ID: 9355235
[TBL] [Abstract][Full Text] [Related]
10. Expression of the plasminogen activator system in the human vascular wall.
Salame MY; Samani NJ; Masood I; deBono DP
Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
[TBL] [Abstract][Full Text] [Related]
11. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman J; Sawdey MS; Keeton MR; Bordin GM; Bernstein EF; Dilley RB; Loskutoff DJ
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6998-7002. PubMed ID: 1495992
[TBL] [Abstract][Full Text] [Related]
12. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
[TBL] [Abstract][Full Text] [Related]
13. Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels.
Falkenberg M; Tjärnström J; Ortenwall P; Olausson M; Risberg B
Thromb Haemost; 1996 Jun; 75(6):933-8. PubMed ID: 8822589
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
Padró T; Steins M; Li CX; Mesters RM; Hammel D; Scheld HH; Kienast J
Cardiovasc Res; 1997 Oct; 36(1):28-36. PubMed ID: 9415269
[TBL] [Abstract][Full Text] [Related]
15. Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes.
Stoop AA; Lupu F; Pannekoek H
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1143-9. PubMed ID: 10764685
[TBL] [Abstract][Full Text] [Related]
16. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.
Dichtl W; Stiko A; Eriksson P; Goncalves I; Calara F; Banfi C; Ares MP; Hamsten A; Nilsson J
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):3025-32. PubMed ID: 10591684
[TBL] [Abstract][Full Text] [Related]
17. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
Sawa H; Lundgren C; Sobel BE; Fujii S
J Am Coll Cardiol; 1994 Dec; 24(7):1742-8. PubMed ID: 7963123
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque.
Robbie LA; Booth NA; Brown AJ; Bennett B
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):539-45. PubMed ID: 8624776
[TBL] [Abstract][Full Text] [Related]
19. Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening.
Hasenstab D; Lea H; Clowes AW
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):853-9. PubMed ID: 10712413
[TBL] [Abstract][Full Text] [Related]
20. Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries.
Lupu F; Heim D; Bachmann F; Kruithof EK
Arterioscler Thromb; 1994 Sep; 14(9):1438-44. PubMed ID: 8068605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
